165 related articles for article (PubMed ID: 36879025)
1. Wearable device and smartphone data quantify ALS progression and may provide novel outcome measures.
Johnson SA; Karas M; Burke KM; Straczkiewicz M; Scheier ZA; Clark AP; Iwasaki S; Lahav A; Iyer AS; Onnela JP; Berry JD
NPJ Digit Med; 2023 Mar; 6(1):34. PubMed ID: 36879025
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal comparison of the self-entry Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-RSE) and Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) as outcome measures in people with amyotrophic lateral sclerosis.
Johnson SA; Burke KM; Scheier ZA; Keegan MA; Clark AP; Chan J; Fournier CN; Berry JD
Muscle Nerve; 2022 Oct; 66(4):495-502. PubMed ID: 35904151
[TBL] [Abstract][Full Text] [Related]
3. Upper limb movements as digital biomarkers in people with ALS.
Straczkiewicz M; Karas M; Johnson SA; Burke KM; Scheier Z; Royse TB; Calcagno N; Clark A; Iyer A; Berry JD; Onnela JP
EBioMedicine; 2024 Mar; 101():105036. PubMed ID: 38432083
[TBL] [Abstract][Full Text] [Related]
4. Design and results of a smartphone-based digital phenotyping study to quantify ALS progression.
Berry JD; Paganoni S; Carlson K; Burke K; Weber H; Staples P; Salinas J; Chan J; Green JR; Connaghan K; Barback J; Onnela JP
Ann Clin Transl Neurol; 2019 May; 6(5):873-881. PubMed ID: 31139685
[TBL] [Abstract][Full Text] [Related]
5. Development and Validation of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS).
Fournier CN; Bedlack R; Quinn C; Russell J; Beckwith D; Kaminski KH; Tyor W; Hertzberg V; James V; Polak M; Glass JD
JAMA Neurol; 2020 Apr; 77(4):480-488. PubMed ID: 31886839
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal comparison of the self-administered ALSFRS-RSE and ALSFRS-R as functional outcome measures in ALS.
Erb MK; Calcagno N; Brown R; Burke KM; Scheier ZA; Iyer AS; Clark A; Higgins MP; Keegan M; Gupta AS; Johnson SA; Chew S; Berry JD
Amyotroph Lateral Scler Frontotemporal Degener; 2024 Mar; ():1-11. PubMed ID: 38501453
[No Abstract] [Full Text] [Related]
7. Tracking amyotrophic lateral sclerosis disease progression using passively collected smartphone sensor data.
Karas M; Olsen J; Straczkiewicz M; Johnson SA; Burke KM; Iwasaki S; Lahav A; Scheier ZA; Clark AP; Iyer AS; Huang E; Berry JD; Onnela JP
Ann Clin Transl Neurol; 2024 Jun; 11(6):1380-1392. PubMed ID: 38816946
[TBL] [Abstract][Full Text] [Related]
8. Chinese validation of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale.
Sun C; Fournier CN; Ye S; Zhang N; Ma Y; Fan D
Eur J Neurol; 2021 Jun; 28(6):1876-1883. PubMed ID: 33686758
[TBL] [Abstract][Full Text] [Related]
9. Patient reported outcomes in ALS: characteristics of the self-entry ALS Functional Rating Scale-revised and the Activities-specific Balance Confidence Scale.
Chew S; Burke KM; Collins E; Church R; Paganoni S; Nicholson K; Babu S; Scalia JB; De Marchi F; Ellrodt AL; Moura LMVR; Chan J; Berry JD
Amyotroph Lateral Scler Frontotemporal Degener; 2021 Nov; 22(7-8):467-477. PubMed ID: 33771057
[No Abstract] [Full Text] [Related]
10. Clinically meaningful change: evaluation of the Rasch-built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) and the ALSFRS-R.
Fournier CN; James V; Glass JD
Amyotroph Lateral Scler Frontotemporal Degener; 2023 May; 24(3-4):311-316. PubMed ID: 36476010
[TBL] [Abstract][Full Text] [Related]
11. Six-Minute Walk Test as a Measure of Walking Capacity in Ambulatory Individuals With Amyotrophic Lateral Sclerosis.
Sanjak M; Langford V; Holsten S; Rozario N; Patterson CGM; Bravver E; Bockenek WL; Brooks BR
Arch Phys Med Rehabil; 2017 Nov; 98(11):2301-2307. PubMed ID: 28465220
[TBL] [Abstract][Full Text] [Related]
12. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group.
Arch Neurol; 1996 Feb; 53(2):141-7. PubMed ID: 8639063
[TBL] [Abstract][Full Text] [Related]
13. Validation of the Italian version of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) administered to patients and their caregivers.
Manera U; Solero L; Fournier CN; Canosa A; Vasta R; Bombaci A; Grassano M; Palumbo F; Torrieri MC; Salamone P; Casale F; Fuda G; Moglia C; Calvo A; Chiò A
Amyotroph Lateral Scler Frontotemporal Degener; 2022 Aug; 23(5-6):424-429. PubMed ID: 34894916
[No Abstract] [Full Text] [Related]
14. Exploratory study to evaluate the acceptability of a wearable accelerometer to assess motor progression in motor neuron disease.
Beswick E; Christides A; Symonds A; Johnson M; Fawcett T; Newton J; Lyle D; Weaver C; Chandran S; Pal S
J Neurol; 2024 May; ():. PubMed ID: 38805054
[TBL] [Abstract][Full Text] [Related]
15. The frequency of ALSFRS-R reversals and plateaus in patients with limb-onset amyotrophic lateral sclerosis: a cohort study.
Hu N; Shen D; Yang X; Cui L; Liu M
Acta Neurol Belg; 2022 Dec; 122(6):1567-1573. PubMed ID: 35034333
[TBL] [Abstract][Full Text] [Related]
16. The MITOS system predicts long-term survival in amyotrophic lateral sclerosis.
Tramacere I; Dalla Bella E; Chiò A; Mora G; Filippini G; Lauria G;
J Neurol Neurosurg Psychiatry; 2015 Nov; 86(11):1180-5. PubMed ID: 25886781
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial.
;
Lancet Neurol; 2017 Jul; 16(7):505-512. PubMed ID: 28522181
[TBL] [Abstract][Full Text] [Related]
18. Patient reported outcome measures (PROMs) in amyotrophic lateral sclerosis.
De Marchi F; Berry JD; Chan J; Caldwell S; Ellrodt A; Scalia J; Burke K; Fang T; Clark Sisodia R; Schwamm LH; Moura LMVR; Paganoni S
J Neurol; 2020 Jun; 267(6):1754-1759. PubMed ID: 32125520
[TBL] [Abstract][Full Text] [Related]
19. Association between nutritional status and disease severity using the amyotrophic lateral sclerosis (ALS) functional rating scale in ALS patients.
Park Y; Park J; Kim Y; Baek H; Kim SH
Nutrition; 2015; 31(11-12):1362-7. PubMed ID: 26429656
[TBL] [Abstract][Full Text] [Related]
20. Creatine for amyotrophic lateral sclerosis/motor neuron disease.
Pastula DM; Moore DH; Bedlack RS
Cochrane Database Syst Rev; 2010 Jun; (6):CD005225. PubMed ID: 20556761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
